UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 85 filers reported holding UROGEN PHARMA LTD in Q2 2020. The put-call ratio across all filers is 1.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $680,000 | -52.1% | 38,139 | -10.5% | 0.01% | 0.0% |
| Q4 2019 | $1,421,000 | +43.0% | 42,590 | +2.1% | 0.01% | +37.5% |
| Q3 2019 | $994,000 | -36.4% | 41,719 | -4.0% | 0.01% | -33.3% |
| Q2 2019 | $1,562,000 | -11.4% | 43,459 | -8.9% | 0.01% | 0.0% |
| Q1 2019 | $1,763,000 | +10.0% | 47,730 | +28.3% | 0.01% | 0.0% |
| Q4 2018 | $1,602,000 | +20.9% | 37,210 | +32.6% | 0.01% | +33.3% |
| Q3 2018 | $1,325,000 | +18.6% | 28,054 | +25.0% | 0.01% | +28.6% |
| Q2 2018 | $1,117,000 | +10.2% | 22,451 | +10.0% | 0.01% | -12.5% |
| Q1 2018 | $1,014,000 | +86.7% | 20,406 | +39.7% | 0.01% | +100.0% |
| Q4 2017 | $543,000 | +46.0% | 14,603 | +23.9% | 0.00% | +33.3% |
| Q3 2017 | $372,000 | +90.8% | 11,790 | +9.1% | 0.00% | +200.0% |
| Q2 2017 | $195,000 | – | 10,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,252,285 | $24,156,000 | 7.72% |
| Horton Capital Management, LLC | 375,428 | $7,242,000 | 6.96% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $56,996,000 | 1.27% |
| Phoenix Holdings Ltd. | 901,979 | $16,405,000 | 0.69% |
| SHIKIAR ASSET MANAGEMENT INC | 44,550 | $859,000 | 0.33% |
| Coastal Bridge Advisors, LLC | 37,000 | $714,000 | 0.22% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $14,242,000 | 0.20% |
| Clal Insurance Enterprises Holdings Ltd | 529,388 | $10,212,000 | 0.17% |
| Vivaldi Capital Management LP | 10,000 | $233,000 | 0.05% |
| MEITAV INVESTMENT HOUSE LTD | 48,407 | $934,000 | 0.05% |